Clinical Trial Update: Efficacy and Safety Study of 4-Day ATG Regimen for Prophylaxis of aGVHD in Matched Sibling Donor PBSCT [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating a 4-day ATG regimen for prophylaxis of acute and chronic GVHD after matched sibling donor peripheral blood stem cell transplanta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• ATG regimen

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: aGVHD, cGVHD | Phase 2 | Status: UNKNOWN